INTRODUCTION
Measles virus (MV), belonging to the genus Morbillivirus of the family Paramyxoviridae, is an enveloped virus with a non-segmented single-stranded negative-sense RNA genome. It encodes two envelope glycoproteins, the haemagglutinin (H) and the fusion (F) proteins required for MV cell entry, a matrix protein (M) and three structural proteins involved in viral genome transcription and replication: the nucleoprotein (N), the phosphoprotein (P) and the large protein (L). The MV genome is encapsidated by N to form the helical nucleocapsid. The N-RNA complex binds to the viral polymerase complex, which consists of the P and L proteins (Curran & Kolakofsky, 1999) . Morbillivirus N consists of two domains: a highly conserved N-terminal moiety (N CORE , aa 1-400) and a poorly conserved Cterminal moiety (N TAIL , aa 401-525) (Diallo et al., 1994) . N CORE is globular and carries regions required for N selfassembly and RNA binding (Bankamp et al., 1996; Curran et al., 1993; Karlin et al., 2002; Liston et al., 1997) . N TAIL is an intrinsically disordered monomeric domain (Longhi et al., 3These authors contributed equally to this work. 2003) and protrudes from the viral nucleocapsid surface, thus ideally favouring the interaction with viral and cellular partners . N TAIL contains the regions responsible for binding to P and to the polymerase complex (Bankamp et al., 1996; Bourhis et al., 2004; Harty & Palese, 1995; Johansson et al., 2003; Liston et al., 1997; Longhi et al., 2003) . N TAIL also binds intracellular partners such as the 70 kDa heat-shock protein (Hsp72) and the interferon responsive factor-3 (IRF-3), which modulate viral RNA synthesis and interferon response, respectively (tenOever et al., 2002; Zhang et al., 2002) . In addition, MV-N interacts with two extracellular cell-surface receptors: the type II IgG Fc receptor (FccRII/CD32) and an as yet uncharacterized receptor referred to as N receptor (NR) (Laine et al., 2003; Ravanel et al., 1997) .
MV infection induces both an efficient specific immune response and transient, but profound, immunosuppression contributing to secondary infections and mortality in humans (Beckford et al., 1985; Griffin, 1995; Miller, 1964) . Virus clearance is ensured by specific immunity against MV proteins, particularly MV-N, which confers long-life protection against reinfection (Etchart et al., 2001; Olszewska et al., 2001) and includes N-specific T lymphocytes (Etchart et al., 2001; Ilonen et al., 1990; Jacobson et al., 1989; Olszewska et al., 2001; van Binnendijk et al., 1989) . Although MV-N is a cytosolic protein, the most abundant and rapidly produced antibodies during MV infection are N specific (Graves et al., 1984; Norrby & Gollmar, 1972) . Thus, anti-N antibody synthesis indicates that MV-N is released into the extracellular compartment, where it binds to the B-cell receptor of antigen (BCR). Indeed, we have previously demonstrated that large amounts of MV-N are extracellularly released in the compartment after apoptosis and/or secondary necrosis of MV-infected cells in vitro (Laine et al., 2003) . By this mechanism, MV-N may become accessible to cell-surface receptors expressed on neighbouring uninfected cells, thereby mediating not only specific immune responses but also immunosuppression.
In contrast to BCR, binding of recombinant MV-N to FccRII and/or NR profoundly disturbs the biology of uninfected B, T and dendritic cells (Laine et al., 2003; Marie et al., 2001; Ravanel et al., 1997) . Three human FccRII isoforms are generated by alternative splicing, differing in their cytoplasmic tails: FccRIIA, -IIB and -IIC (Ravetch & Bolland, 2001; Tsubata, 1999) . While the FccRIIA is critical for antigen-presenting-cell activation, FccRIIB1 downregulates B-cell functions (Malbec et al., 1999; Reth, 1989) . Both human and murine FccRII isoforms bind the immune complexes (Cohen-Solal et al., 2004) and MV-N with low avidity (Ravanel et al., 1997) . Consequently, MV-N binding to FccRIIB was shown to block inflammatory immune responses in a murine model (Marie et al., 2001) . MV-N also prevents in vitro interleukin 12 production by human CD40-activated monocyte-derived dendritic cells (ServetDelprat et al., 2003) , probably after FccRIIB aggregation (Grazia Cappiello et al., 2001) . In contrast to FccRII, NR is expressed on the surface of a large spectrum of normal cells, except human and murine resting T cells (Laine et al., 2003) . NR detection on different cell species favours ubiquitous and conserved NR expression. Alternatively, MV-N may bind to a group of various receptors sharing similar binding properties. MV-N binding to human NR suppresses normal thymic epithelial and mitogen-activated T-cell proliferation by blocking cells in the G 0 /G 1 phases of the cell cycle (Laine et al., 2003) . Finally, in vitro antibody synthesis of activated human B lymphocytes expressing both FccRIIB and NR is dramatically reduced in the presence of MV-N (Ravanel et al., 1997) .
In this work, we aimed to map the MV-N domains involved in the interaction with FccRIIB1 and NR and to determine the relative contribution of each receptor to the suppression of cell proliferation and to apoptosis. To this end, we used a melanoma cell line expressing or not expressing FccRIIB1 as a model. We showed that MV-N binds to human FccRIIB1 and NR through N CORE and N TAIL , respectively. While FccRIIB1 interaction with N CORE triggered apoptosis, the aa 401-420 region of MV-N acted predominantly by blocking cell proliferation in the G 0 /G 1 phases of the cell cycle after binding to NR. Therefore, MV-N displays different suppressive activities depending on whether N CORE or N TAIL binds to its respective cell-surface receptor.
METHODS
Antibodies. The monoclonal antibodies (mAbs) used were: biotinylated anti-MV-N Cl25 (Giraudon & Wild, 1981) , biotinylated anti-MV-N Cl120 (Giraudon & Wild, 1981) and anti-FLAG (clone M2; Sigma-Aldrich). The blocking mouse mAb KB61 recognizing all human FccRII isoforms was kindly provided by D. Y. Mason (Pulford et al., 1986) . Phycoerythrin (PE)-conjugated anti-human FccRII (C1KM5 clone; Caltag Laboratories) mAb was also used. The secondary antibody used was PE-conjugated goat F(ab9) 2 fragment anti-mouse IgG (PE-GAM) from Immunotech. Streptavidin-PE (Av-PE; Caltag Laboratories) and mouse IgG1 and IgG2 isotypic controls (Immunotech) were also used.
Cell lines. The human melanoma cell line HT144, which does not express FccRII, was stably transfected with human FccRIIB1 cDNA (HT144IIB1) or with human FccRIIB1 cDNA lacking the intracytoplasmic tail (HT144IIB1/IC 2 ) (Cassard et al., 2002) . The murine fibroblast L Orient cells transfected with human FccRII cDNA (L-CD32) were kindly provided by S. Lebecque (ScheringPlough, Dardilly, France). Cell lines were grown in RPMI 1640 (Invitrogen) supplemented with 2 mM L-glutamine (Invitrogen), 10 mM HEPES (Invitrogen), 40 mg gentamicin (Schering-Plough) ml 21 and 10 % fetal calf serum (Biomedia).
Production of MV-N, N CORE and N TAIL . Recombinant MV-N (strain Edmonston B) was produced from Escherichia coli as previously described (Karlin et al., 2002) . N CORE was obtained by limited proteolysis of purified N as described by Karlin et al. (2002) , and N TAIL (strain Edmonston B) was purified as described elsewhere (Laine et al., 2003; Longhi et al., 2003) . (Bourhis et al., 2004) , encoded aa 401-488 of MV-N. The sequences of the coding regions were checked by sequencing (MilleGen).
E. coli strain Rosetta (DE3) pLysS (Novagen) was used for the expression of N TAIL deletion constructs. Culture and induction conditions were as described by Longhi et al. (2003) , except that chloramphenicol (17 mg ml 21 ) was used instead of kanamycin.
Expression of tagged full-length N TAIL from the pQE32 vector was carried out as described by Longhi et al. (2003) .
Purification of N TAIL proteins was carried out as described by Longhi et al. (2003) . The proteins were purified by immobilized metal affinity chromatography (IMAC) using Chelating Sepharose Fast Flow Resin preloaded with Ni 2+ ions (Amersham Pharmacia Biotech).
Protein concentrations were calculated as described by Longhi et al. (2003) .
Detection of FccRII. Direct immunofluorescence assays were performed in staining buffer (PBS containing 1 % BSA and 0?1 % sodium azide) as described by Laine et al. (2003) . After labelling, cells were analysed (Cellquest software) by flow cytometry analysis using a Calibur flow cytometer (Becton Dickinson). Integrated fluorescence was measured and data were collected from at least 10 000 events.
Detection and competition of MV-N binding by flow cytometry. To determine MV-N binding to cells, 5610 5 cells were incubated for 1 h at 4 uC with 5 mg purified N (50 mg ml 21 ) in the presence or absence of anti-FccRII mAb KB61 (10 mg ml 21 ) in staining buffer. After washes, cells were incubated for 30 min at 4 uC with either biotinylated mAbs (C120 and Cl25) or mAb M2 specific for FLAG fusion proteins. Cells were then incubated with either Av-PE or PE-GAM for 30 min at 4 uC.
Competition experiments were performed using N TAIL deletion proteins as competitors. MV-N (2?5 mg; 25 mg ml
21
) was incubated with increasing amounts of N TAIL deletion proteins for 1 h at 4 uC. Cells were then incubated with biotinylated anti-N Cl120 mAb, followed by Av-PE incubation. The mean fluorescence intensity (MFI) of MV-N binding was measured after analysis by flow cytometry.
Cell proliferation and cell-cycle analyses. Cells were plated at 3?5610 4 cells cm 22 for 24 h in a volume of 700 ml cm 22 . For cell proliferation assays, cells were seeded in triplicate in a 96-well plate and incubated with various amounts of MV-N or domains thereof. After 12 h of treatment, 0?5 mCi (18?5 kBq) [
3 H]thymidine per well was added for 24 h as described by Laine et al. (2003) .
For cell-cycle analysis, cells were stained with 7-amino-actinomycin D (7AAD) and pyronin Y (PY) (Toba et al., 1995) . Briefly, 20 mM 7AAD was incubated with 5610 5 cells and 1 mM PY was then added. Cells were analysed by flow cytometry. Data were collected from at least 20 000 events.
Apoptosis detection. Cells were plated at 3?5610 4 cells cm 22 for 24 h in a volume of 700 ml cm 22 prior to the addition of MV-N or domains thereof. Percentages of attached and floating cells with activated pan-caspase were estimated after staining with the in situ marker FITC-VAD-FMK (CaspACE), a FITC conjugate of the pan-caspase inhibitor zVAD-FMK, as described by the manufacturer (Promega). Percentages of attached cells with activated caspase-3 were estimated after staining with the in situ marker FITC-DEVD-FMK (BioVision), as described by the manufacturer. For the assessment of nuclear features of apoptosis, attached cells were stained with Hoechst 33342 (10 mg ml 21 ) for 30 min at 37 uC, as previously described (Valentin et al., 1999) .
RESULTS
N CORE and N TAIL domains of MV-N bind to human FccRIIB1 and NR, respectively MV-N is composed of N CORE and N TAIL domains (Fig. 1a) . To investigate the MV-N domains responsible for binding to cell-surface receptors, we used either human melanoma HT144 cells expressing only NR or HT144IIB1 cells expressing both FccRIIB1 and NR as a model (Fig. 1b) . As anti-MV-N mAb Cl120 reacted strongly with the cell surface of HT144IIB1 cells, anti-FLAG antibody was used for specific detection of MV-N and N CORE binding, while biotinylated Cl25 mAb was used to detect N TAIL (Fig. 1a) . HT144 cells efficiently bound MV-N and N TAIL , but not N CORE , whatever amount was used (Fig. 1c , and data not shown), confirming that binding of N TAIL , but not of N CORE , occurs through human NR. These results indicated that NR expression is not restricted to normal cells but that it is also expressed on malignant cell lines (Laine et al., 2003) . In addition, N TAIL binding to NR on HT144IIB1 cells did not affect FccRII expression, as judged by the superimposition of the histogram compared with the controls (data not shown). Conversely, HT144IIB1 cells bound MV-N, N TAIL and also N CORE , strongly suggesting that N CORE binding occurs through human FccRIIB1 (Fig. 1c) . In most experiments, N CORE bound to HT144IIB1 to a lower extent than MV-N, even if large amounts of N CORE were used (68 mg per well; data not shown).
To confirm that N CORE interacts with FccRIIB1, we performed blocking experiments using anti-FccRII mAb KB61. Biotinylated Cl120 and Cl25 mAbs were used to detect N CORE and N TAIL binding, respectively (Fig. 1a) . Therefore, we used L-CD32 cells (Fig. 1b) , since biotinylated Cl120 mAb cross-reacted slightly with these cells. As illustrated in Fig. 1(d) , L-CD32 cells efficiently bound MV-N, N TAIL and N CORE . As expected, the addition of KB61 mAb partially inhibited MV-N binding to L-CD32 cells (Fig. 1d) . Interestingly, N CORE was responsible for binding to FccRII, as judged by the complete inhibition of binding to L-CD32 cells in the presence of KB61 mAb (Fig. 1d) . The fact that N CORE binding to L-CD32 cells in the presence of the high-affinity FccRII inhibitory antibody KB61 was lower than that observed with the negative control (dashed line) may be accounted for by the cross-reactivity of Cl120 mAb with L-CD32 cells. Thus, the addition of KB61 mAb would block N CORE binding as well as non-specific binding of Cl120 mAb to L-CD32 cells. As expected, N TAIL binding to murine NR expressed on L-CD32 cells was not affected by KB61 mAb, as indicated by the superimposition of the histogram profiles obtained with and without anti-FccRII mAb (Fig. 1d) . Similarly, KB61 mAb did not affect N TAIL binding to NR expressed on either HT144 or HT144IIB1 cells (data not shown). Moreover, L Orient cells bound MV-N and N TAIL , but not N CORE (data not shown). Taken together, these results indicated the presence of N COREFccRIIB1 and N TAIL -NR interactions.
Both N CORE and N TAIL domains of MV-N inhibit spontaneous cell proliferation
We next determined the contribution of the N CORE and N TAIL domains to the suppression of cell proliferation through their interactions with FccRIIB1 and NR, respectively. As shown in Fig. 2(a) , MV-N and N TAIL , but not N CORE , inhibited up to 95 % of HT144 cell proliferation. The apparent higher anti-proliferative activity of N TAIL compared with that of full-length MV-N could be accounted for by differences in the molar amounts of receptor engaged. As the molecular mass of N TAIL is approximately 15 kDa and that of N is approximately 60 kDa, a fourfold excess of N, compared with N TAIL , has to be added to yield the same molar amount and the same biological effect.
In contrast, N CORE , as MV-N and N TAIL , inhibited HT144IIB1 cell proliferation by up to 60 % (Fig. 2b) . Thus, the apparent discrepancy in the inhibitory effect between N TAIL and MV-N was more pronounced in HT144 cells than in HT144IIB1 cells (Fig. 2a versus b) . This phenomenon was due to cumulative binding effects, i.e. the fact that MV-N binds to both FccRIIB1 and NR in HT144IIB1, while it binds only to NR in HT144 cells. In all cases, the observed inhibition was dose dependent (Fig. 2a and b) , indicating that inhibition of cell proliferation specifically relies upon either N CORE -FccRIIB1 or N TAIL -NR interactions.
We next analysed the cell-cycle distribution of MV-N-, N CORE -or N TAIL -treated HT144 and HT144IIB1 cells by measuring the DNA/RNA contents. We observed a significant increase in the percentage of both cell types arrested in the G 0 /G 1 phases (up to 35 %) after MV-N treatment compared with untreated cells (Fig. 2c) . Subsequently, a decrease in the percentage of MV-N-treated cells in both S and G 2 /M phases of the cell cycle by day 1 was observed (data not shown). Similar results were obtained with N TAIL but the difference was less marked (Fig. 2c , and data not shown). As N CORE -FccRIIB1 interaction triggers cell apoptosis through caspase-3 activation HT144IIB1 cells treated with MV-N or N CORE , but not those treated with N TAIL , appeared dispersed and damaged compared with untreated cells, with some detaching and displaying apoptotic morphology (Fig. 3) . When MV-N or N TAIL were added to HT144 cells, the monolayers also appeared dispersed, enlarged and displayed a round shape, although they remained attached to the culture dish, while the addition of N CORE did not have this effect (Fig. 3) . These results indicate that both MV-N and N CORE , but not N TAIL , efficiently trigger HT144IIB1 cell death through FccRIIB1.
We next investigated whether MV-N and N CORE mediated apoptosis via FccRIIB1 by measuring caspase activation. Interestingly, HT144IIB1 cells underwent apoptosis when cultured with either MV-N (38?9 %) or N CORE (20?6 %), while N TAIL only slightly increased the level of apoptosis (5?9 %) compared with untreated cells (0?5 %; Fig. 3 ). Apoptosis of HT144IIB1 cells was also observed after CD32 cross-linking by Abs (AT10/CD32 plus rabbit anti-mouse, data not shown), suggesting that apoptosis resulted from clustering of FccRIIB1. A lower degree of apoptosis was observed in HT144 cells treated with MV-N and N TAIL (8?5 and 3?3 %; Fig. 3 ) compared with N CORE (1?6 %). These results strongly suggested that N CORE -induced FccRIIB1 clustering triggered apoptosis, while NR-mediated apoptosis appeared to provide a minor contribution. In order to demonstrate that N CORE -induced apoptosis was strictly dependent on FccRIIB1 clustering, we performed experiments on HT144 cells expressing FccRIIB1 but lacking its intra-cytoplasmic tail (HT144IIB1/IC 2 ). In these cells, no signal can be transduced via FccRII clustering. As expected, MV-N, N CORE and N TAIL bound to HT144IIB1/IC 2 cells and the cells expressed FccRIIB1 at a level similar to that of HT144IIB1 cells (Fig. 4a, and data not shown) . Interestingly, neither MV-N nor N CORE triggered significant caspase-3 activation in HT144IIB1/IC 2 cells (Fig. 4b) , even though in some cases N CORE -binding detection was higher than that currently observed (data not shown). In contrast, MV-N and N CORE induced 24?7 and 14?2 % caspase-3 activation in HT144IIB1 cells, respectively (Fig. 4b) . As expected, HT144IIB1 cells underwent apoptosis following the addition of either MV-N or N CORE as shown by nuclear condensation and fragmentation, in contrast to HT144IIB1/IC 2 cells (Fig. 5a ). Whichever cell line was used, N TAIL was not toxic, even with doses as high as 68 mg per well, as judged by pan-caspase activation, caspase-3 activation and Hoechst staining (Fig. 4b, 5a , and data not shown).
To demonstrate further that caspase activation was involved in MV-N-and N CORE -induced apoptosis through interaction with FccRIIB1, cells were incubated in the presence of the pan-caspase inhibitor zVAD-FMK and nuclear morphology was analysed at day 1. In HT144IIB1 cells treated with MV-N and N CORE , zVAD-FMK totally inhibited apoptosis, and the nuclei of untreated or N TAIL -treated cells remained intact (Fig. 5b) . Taken together, these data demonstrated that both MV-N and N CORE specifically trigger apoptosis via binding to FccRIIB1 in a caspase-3-dependent manner.
Binding of conserved Box1 of Morbillivirus N TAIL to NR suppresses spontaneous cell proliferation
In addition to the N TAIL domain of MV-N, three different N proteins derived from various members of the genus Morbillivirus also bind to human NR (Laine et al., 2003) . We thus hypothesized that the region(s) involved in NR binding may be located in one of the three conserved regions in the Morbillivirus N TAIL (aa 401-420, 489-506 and 517-525) (Diallo et al., 1994) . To test this possibility, we purified three N TAIL deletion proteins carrying different combinations of such boxes, N TAILD1 , N TAILD2,3 and N TAILD3 (Fig. 6a) . These deletion proteins were all found in the soluble fraction of the bacterial lysate (Fig. 6b) and were purified by IMAC (Fig. 6b) .
We then compared the ability of the N TAILD1 , N TAILD2, 3 and N TAILD3 deletion proteins to bind to NR. Biotinylated Cl25 mAb was used to detect specific binding of these deletion proteins to HT144 cells. As shown in Fig. 6(c) , both N TAILD3 and N TAILD2,3 bound to NR, demonstrating that Box2 and Box3 are dispensable for NR binding. On the other hand, no detectable N TAILD1 binding to NR was observed, even with amounts as high as 20 mg per well (data not shown), indicating that N TAIL binding strictly requires Box1. Similar results were obtained when binding of deletion proteins was revealed with anti-FLAG mAb (data not shown). Binding of N TAILD3 and N TAILD2,3 , but not N TAILD1 , was also observed on both murine L and human thymic epithelial cell lines (data not shown). The intrinsic disorder of N TAIL rules out the possibility that the inability of N TAILD1 to bind to cells may arise from structural changes induced by removal of Box1. We further performed competition experiments by co-incubating MV-N with increasing amounts of N TAIL deletion proteins. Binding of MV-N was then detected using biotinylated Cl120 mAb, specifically recognizing the N CORE domain. Both N TAILD3 and N TAILD2,3 significantly inhibited MV-N binding (19-76 %) in a dose-dependent manner, whereas N TAILD1 failed to do so (Fig. 6d) . Collectively, these results support the conclusion that the region responsible for specific binding to NR is located within aa 401-420 of MV-N.
Finally, we investigated whether NR engagement by the deletion proteins affected HT144 cell proliferation. As illustrated in Fig. 6(e) , N TAILD2,3 and N TAILD3 deletion proteins inhibited human cell proliferation in a dosedependent manner, although to a lower extent than N TAIL . As expected, N TAILD1 was unable to inhibit HT144 cell proliferation, even at concentrations as high as 20 mg per well (Fig. 6e) . Similar results were obtained using L and thymic epithelial cell lines (data not shown). Thus, the aa 401-420 region of MV-N is required for NR binding and, as a result, is responsible for cell proliferation inhibition.
DISCUSSION
The mechanisms responsible for MV-induced immunosuppression are multifactorial and involved MV-infected immune cells, apoptosis of both MV-infected and uninfected cells, interference with cytokine synthesis, induction of soluble inhibitory factors and abnormalities in both antigen-presenting cell and lymphocyte functions (Gerlier et al., 2005; Schneider-Schaulies & ter Meulen, 2002) . However, the overall frequency of infected peripheral blood lymphocytes is usually low during viraemia, supporting the notion that indirect mechanisms based on viral protein effects are mainly involved. Thus, the F-H complex binding to an as yet unknown receptor on uninfected T cells was shown to disrupt intracellular signalling pathways leading to the inhibition of lymphocyte proliferation (Avota et al., 2001) . Likewise, MV-N exerts a suppressive activity after interaction with cell-surface receptors expressed on uninfected cells (Gerlier et al., 2005) . In the present study, we have identified the MV-N domains involved in binding to human FccRIIB1 and NR, and shown that MV-N mediates either suppression of cell proliferation or apoptosis, depending on the type of receptor involved.
Our results point to an exclusive interaction of N CORE with FccRIIB1 and show that MV-N binds to FccRIIB1 more efficiently than N CORE . This latter point is probably related to the increased rigidity of N CORE compared with N , which possibly renders sequential and/or conformational epitopes less accessible to FccRIIB1.
FccRIIB1 is not a receptor responsive to any nucleocapsidlike particles. While the N of MV, canine distemper virus (CDV) and peste-des-petits-ruminants virus (PPRV) bind to FccRIIB1, rinderpest virus (RPV) N does not (Laine et al., 2003) , thus supporting specific N CORE binding to FccRIIB1. The distinctive behaviour of RPV-N may be due to its unique sequence properties within the putative region of interaction with FccRIIB1. Although the amino acid sequence of N CORE is well conserved among Morbillivirus members (overall sequence similarity of 80 %), the similarity drops to 40 % for the aa 122-144 region (Diallo et al., 1994) . This variable region, already described as an antigenic region (Giraudon et al., 1988) , is low in hydrophobic clusters and may therefore form a loop exposed to the solvent , possibly involved in binding to FccRIIB1. The conserved serine 138, occurring in MV-N, CDV-N and PPRV-N, is replaced by a glycine residue in RPV-N (Diallo et al., 1994) . This substitution may lead to a conformational change in RPV-N, thus resulting in a spatial conformation unsuitable for the proper interaction with FccRIIB1. N TAILD3 , N TAILD2, 3 and N TAILD1 mutants are devoid of Box3, Box2 plus Box3, and Box1, respectively. The three N TAIL deletion proteins contained a six-His tag fused to their N terminus (white boxes) and a C-terminal FLAG (black boxes). The a-helical molecular recognition element, i.e. the region involved in induced folding of N TAIL through binding to P (Bourhis et al., 2004) , is indicated as an a-helix. Interestingly, the RPV-N C-terminal domain is more antigenic than its N-terminal counterpart. Among the three highly immunogenic epitopes located at both the C and N terminus of RPV-N, only one (aa 520-525) is conserved in MV N TAIL (aa 519-523) (Buckland et al., 1989; Choi et al., 2003 Choi et al., , 2004 . These results suggest that the Morbillivirus N epitopes involved in immune activation are different from the regions involved in binding to cellsurface receptors and thus in immunosuppression.
We showed that NR binds Box1 (aa 401-420), which is well conserved among Morbillivirus members (Diallo et al., 1994) . Moreover, Box1 is also well conserved among wildtype and vaccine MV strains, as judged by the comparison between the amino acid sequence of N TAIL from the Edmonston B, other vaccine strains and 48 wild-type strains. Four conservative substitutions (T402A, I406T/V, A415S and L420I) occur individually in eight wild-type strains, and the conservative K405R substitution is observed in the majority of the wild-type strains (D. W. Kouomou & F. T. Wild, personal communication) . This latter substitution is also observed in other Morbillivirus N capable of interacting with NR (Diallo et al., 1994; Laine et al., 2003) . This analysis also revealed complete conservation of the sequence in the aa 407-414 region between Edmonston B and all of the wild-type strains. Thus, the high conservation of Box1 highlights the biological relevance of studies focused on the interaction between NR and N TAIL from Edmonston MV strain.
We also reported that cell-cycle arrest was mediated predominantly by the N TAIL -NR interaction in a human melanoma line, whereas apoptosis was mediated primarily by the N CORE -FccRIIB1 interaction in melanoma cells expressing FccRIIB1. FccRIIB1 aggregation by antibodies also results in inhibition of spontaneous and activated B-cell proliferation (Pearse et al., 1999) . Few data are available concerning the role of N from single-stranded RNA viruses in the modulation of cell proliferation. The only available data concern the role of intracellular N from Borna disease virus and hepatitis C virus in blocking cell proliferation through interaction with cell-cycle regulators (Planz et al., 2003; Yao et al., 2003) . As no inhibition of cell proliferation has been documented so far for intracellular MV-N, our results strongly suggest that the effect of N CORE -FccRIIB1 interaction on cell proliferation can be ascribed to B cells, while the N TAIL -NR interaction inhibits both B-and T-cell proliferation. Similarly, both wild-type and vaccine MV strains suppress both infected and uninfected B-and T-cell proliferation in vitro (Gerlier et al., 2005; Hahm et al., 2003; McChesney et al., 1987 McChesney et al., , 1988 Naniche et al., 1999; Schlender et al., 1996) . There are a several lines of evidence suggesting that cell growth arrest cannot be ascribed to infectious virus or conventional cytokines Sanchez-Lanier et al., 1988; Sun et al., 1998) . In addition to the role of H/F proteins from MV, RPV and PPRV (Heaney et al., 2002; Schlender et al., 1996) , soluble anti-proliferative factors produced from dead MV-infected cells arrest uninfected B and T cells in the G 0 /G 1 phases Wang et al., 2003) . As MV-N is released from apoptotic MV-infected cells (Gerlier et al., 2005) , it would be interesting to determine whether MV-N is the factor responsible for growth arrest. In addition to the potent antiproliferative effect of MV-N, aggregation of FccRIIB1 by N CORE triggers apoptosis via the intra-cytoplasmic tail of FccRIIB1. Previous data have already demonstrated that cross-linking of murine FccRIIB by a combination of antibodies is sufficient to induce apoptosis of B cells independent of BCR co-ligation (Pearse et al., 1999) . However, the link between inhibition of cell proliferation and induction of apoptosis mediated by both MV-N and N CORE after binding to FccRIIB1 is difficult to establish, and we cannot exclude the possibility that the induction of apoptosis is the consequence of suppression of cell proliferation. To our knowledge, only hepatitis C virus CORE protein has been described to exert a pro-apoptotic effect in transfected cells (Realdon et al., 2004) . Apoptosis of uninfected B and T lymphocytes by MV, CDV and PPRV has been described, and lymphopenia, primarily due to apoptosis of uninfected lymphocytes, seems to arise mainly from indirect effects of the viruses (Gerlier et al., 2005; Mondal et al., 2001; Okada et al., 2000; Schobesberger et al., 2005) . Although RPV-induced apoptosis has been ascribed to direct cytopathogenic RPV infection (Stolte et al., 2002) , we hypothesize that the four Morbillivirus members trigger cell growth arrest via N TAIL -NR interaction, with MV, CDV and PPRV being also involved in N COREFccRIIB1-induced apoptosis. The severe lymphopenia observed with measles patients does not occur with the vaccine strains (Okada et al., 2001) . In the cotton rat model, wild-type MV strains induce a higher anti-proliferative effect than vaccine strains through H/F glycoproteins (Niewiesk et al., 1997; Pfeuffer et al., 2003) . However, high-titre measles vaccine administration to young infants increased mortality, thus suggesting that vaccine virus may mimic the immunosuppressive effects of wild-type MV (Moss & Polack, 2001) . Thus, further studies are necessary to understand in more detail the contribution of MV-N to the mechanisms of immunosuppression following MV infection. Finally, the potential effect of MV-N on cell death via FccRIIB, in addition to its potent and global anti-proliferation effect via NR, may represent a promising approach for the local treatment of cancer cells expressing FccRIIB, as well as for cell-cycle manipulation of rapidly proliferating cells expressing NR.
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